FR2696464B1
(fr)
*
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
|
FR2697522B1
(fr)
*
|
1992-10-30 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
FR2698361B1
(fr)
*
|
1992-11-20 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'un acide oxazolidine-1,3 carboxylique-5.
|
IL107950A
(en)
|
1992-12-15 |
2001-04-30 |
Upjohn Co |
b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
|
US5973160A
(en)
*
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
JPH09511212A
(ja)
*
|
1993-06-11 |
1997-11-11 |
ジ・アップジョン・カンパニー |
Δ▲上6▼,▲上7▼−タキソール類の抗悪性腫瘍的使用およびそれらを含む医薬組成物
|
FR2706457B1
(fr)
*
|
1993-06-16 |
1995-07-28 |
Rhone Poulenc Rorer Sa |
Procédé de préparation d'un acide oxazolidinecarboxylique utile pour préparer des taxoïdes thérapeutiquement actifs.
|
US6005120A
(en)
|
1993-07-20 |
1999-12-21 |
Florida State University |
Tricyclic and tetracyclic taxanes
|
JPH09505050A
(ja)
*
|
1993-11-12 |
1997-05-20 |
ジ・アップジョン・カンパニー |
ピリミジン−チオアルキルおよびアルキルエーテル化合物
|
IL127599A
(en)
*
|
1994-01-28 |
2004-06-01 |
Upjohn Co |
Process for preparing isotaxol analogs
|
US5679807A
(en)
*
|
1995-01-30 |
1997-10-21 |
Hauser, Inc. |
Preparation of taxol and docetaxel through primary amines
|
CA2170661A1
(en)
*
|
1995-03-22 |
1996-09-23 |
John K. Thottathil |
Novel methods for the preparation of taxanes using oaxzolidine intermediates
|
GB9512471D0
(en)
*
|
1995-06-20 |
1995-08-23 |
Pharmacia Spa |
Method for the preparation of taxol and its derivatives
|
US5688977A
(en)
*
|
1996-02-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for docetaxel synthesis
|
NZ332475A
(en)
*
|
1996-05-08 |
2000-05-26 |
Upjohn Co |
silylated baccatin derivatives, 3-(substituted amino)-3-phenyl-(2R,3S)-isoserinate derivatives, the oxazolidine ester thereof and other immediates used to prepare baccatin derivatives
|
US7288665B1
(en)
|
1997-08-18 |
2007-10-30 |
Florida State University |
Process for selective derivatization of taxanes
|
CN1150149C
(zh)
|
1997-08-21 |
2004-05-19 |
佛罗里达州立大学 |
紫杉烷类化合物的合成方法
|
AU1712899A
(en)
*
|
1997-12-23 |
1999-07-12 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
AU2001288805A1
(en)
|
2000-09-22 |
2002-04-02 |
Bristol-Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
US6891050B2
(en)
*
|
2001-08-10 |
2005-05-10 |
Dabur India Limited |
Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
|
US6881852B2
(en)
*
|
2002-02-05 |
2005-04-19 |
Dabur India Limited |
Process of purification of paclitaxel and docetaxel
|
US7247738B2
(en)
*
|
2002-05-07 |
2007-07-24 |
Dabur India Limited |
Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
|
US6900342B2
(en)
*
|
2002-05-10 |
2005-05-31 |
Dabur India Limited |
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
ES2331791T5
(es)
*
|
2002-06-26 |
2016-01-21 |
Medigene Ag |
Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo
|
AU2003273671A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Phytogen Life Sciences, Inc. |
Novel taxanes and methods related to use and preparation thereof
|
US6838569B2
(en)
|
2002-12-16 |
2005-01-04 |
Dabur India Limited |
Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
|
EP1633317A4
(en)
|
2003-05-16 |
2008-08-20 |
Intermune Inc |
Synthetic chemokine receptor ligands and methods of use therefor
|
WO2005040758A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US7202370B2
(en)
*
|
2003-10-27 |
2007-04-10 |
Conor Medsystems, Inc. |
Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
|
JP2008513356A
(ja)
*
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
EP1712552A1
(en)
*
|
2005-04-11 |
2006-10-18 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
EP1647552A1
(en)
*
|
2004-10-08 |
2006-04-19 |
INDENA S.p.A. |
Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
|
US7446126B2
(en)
*
|
2004-10-08 |
2008-11-04 |
Indena S.P.A. |
Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
|
US8691780B2
(en)
*
|
2005-02-17 |
2014-04-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
KR20080100264A
(ko)
*
|
2006-03-21 |
2008-11-14 |
닥터 레디스 레보러터리즈 리미티드 |
도세탁셀의 다형체와 그 제조방법
|
MX2008011978A
(es)
|
2006-03-22 |
2009-04-22 |
Medigene Ag |
Tratamiento del cancer de seno negativo al triple receptor.
|
ITMI20062479A1
(it)
*
|
2006-12-21 |
2008-06-22 |
Indena Spa |
Processo per la preparazione di secotassani
|
EP2151363B1
(en)
*
|
2007-05-30 |
2011-08-17 |
Mitsubishi Electric Corporation |
Brake controller of electric vehicle
|
EP2296645B1
(en)
|
2008-05-22 |
2014-11-19 |
Galera Therapeutics, LLC |
Combination antitumor therapy
|
KR101003822B1
(ko)
|
2008-06-20 |
2010-12-27 |
주식회사 셀트리온화학연구소 |
도세탁셀의 제조방법 및 도세탁셀의 제조를 위한 신규한중간체
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
CN101735179B
(zh)
*
|
2008-11-19 |
2012-09-12 |
上海百灵医药科技有限公司 |
一种多烯紫杉醇的制备方法,其中间体及制备方法
|
EP2358693A4
(en)
*
|
2008-11-20 |
2012-04-18 |
Reddys Lab Ltd Dr |
PREPARATION OF DOCETAXEL
|
PL388144A1
(pl)
|
2009-05-29 |
2010-12-06 |
Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością |
Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
|
EP3539563A1
(en)
|
2012-07-19 |
2019-09-18 |
Redwood Bioscience, Inc. |
Antibody specific for cd22 and methods of use thereof
|
CN104884056A
(zh)
|
2012-11-12 |
2015-09-02 |
雷德伍德生物科技股份有限公司 |
用于制备缀合物的化合物和方法
|
JP6450690B2
(ja)
|
2013-02-15 |
2019-01-09 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
キメラ抗原受容体及びその使用方法
|
JP6410790B2
(ja)
|
2013-03-14 |
2018-10-24 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法
|
EP3074010A4
(en)
|
2013-11-27 |
2017-10-25 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
JP6615769B2
(ja)
|
2014-02-19 |
2019-12-04 |
アルデア ファーマシューティカルズ インコーポレイテッド |
ミトコンドリアアルデヒドデヒドロゲナーゼ2(aldh2)に結合する多環式アミド
|
PE20211798A1
(es)
|
2014-03-21 |
2021-09-13 |
Abbvie Inc |
Anticuerpos y conjugados de anticuerpo y farmaco anti-egfr
|
US10654875B2
(en)
|
2015-11-12 |
2020-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
EP3231421A1
(en)
|
2016-04-11 |
2017-10-18 |
Greenaltech, S.L. |
Uses of a carotenoid in the treatment or prevention of stress induced conditions
|
CA3019398A1
(en)
|
2016-04-26 |
2017-11-02 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
SI3463308T1
(sl)
|
2016-06-01 |
2022-04-29 |
Servier IP UK Limited |
Formulacije polialkilenoksidne asparaginaze in postopki za pripravo in uporabo le-teh
|
CN116284404A
(zh)
|
2016-06-08 |
2023-06-23 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
MX2018015272A
(es)
|
2016-06-08 |
2019-08-12 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
BR112018075653A2
(pt)
|
2016-06-08 |
2019-08-27 |
Abbvie Inc |
anticorpos anti-b7-h3 e conjugados anticorpo fármaco
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗bh7−h3抗体及び抗体薬物コンジュゲート
|
CN109562169A
(zh)
|
2016-06-08 |
2019-04-02 |
艾伯维公司 |
抗cd98抗体及抗体药物偶联物
|
TW201825087A
(zh)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
胰臟癌治療
|
EP3571229A1
(en)
|
2017-01-18 |
2019-11-27 |
F1 Oncology, Inc. |
Chimeric antigen receptors against axl or ror2 and methods of use thereof
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
JP2021512110A
(ja)
|
2018-01-31 |
2021-05-13 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーGalera Labs, Llc |
ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法
|
WO2019200181A1
(en)
|
2018-04-11 |
2019-10-17 |
Ohio State Innovation Foundation |
Methods and compositions for sustained release microparticles for ocular drug delivery
|
EP3823674A4
(en)
|
2018-07-18 |
2022-12-28 |
Manzanita Pharmaceuticals, Inc. |
CONJUGATES FOR DELIVERING AN ANTI-CANCER AGENT TO NERVE CELLS, METHODS OF USE AND METHODS OF PRODUCTION THEREOF
|
JP2022527860A
(ja)
|
2019-04-02 |
2022-06-06 |
ケンジョッケティ バイオテクノロジー,インク. |
排出ポンプ-癌抗原マルチ特異性抗体ならびにそれに関する組成物、試薬、キットおよび方法
|
WO2021155028A1
(en)
|
2020-01-29 |
2021-08-05 |
Kenjockety Biotechnology, Inc. |
Anti-mdr1 antibodies and uses thereof
|
WO2021247423A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
WO2021247426A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Anti-abcg2 antibodies and uses thereof
|
EP4208483A1
(en)
|
2020-09-02 |
2023-07-12 |
Kenjockety Biotechnology, Inc. |
Anti-abcc1 antibodies and uses thereof
|
EP4244257A1
(en)
|
2020-11-13 |
2023-09-20 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
CA3238353A1
(en)
|
2021-12-13 |
2023-06-22 |
William Robert ARATHOON |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|